Article
Pathogenic mutations in the carboxyl-terminal domain of glutaryl-CoA dehydrogenase: effects on catalytic activity and the stability of the tetramer.
Molecular genetics and metabolism - 1 Aug 2003
Westover Jonna B, Goodman Stephen I, Frerman Frank E
Abstract excerpt
Inherited defects in glutaryl-CoA dehydrogenase cause the neurometabolic disease, glutaric acidemia type I. Five of over 80 mutations that have been identified are located in a carboxyl-terminal domain. The five mutations were generated by site directed mutagenesis and expressed in Escherichia coli. The mutant dehydrogenases were purified and characterized by circular dichroism and fluorescence spectroscopy,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
